Ubrogepant(MK-1602)是一种新型口服降钙素基因相关肽受体(CGRP)拮抗剂，正在开发治疗急性偏头痛。
货号:ajcx12372
CAS:1374248-77-7
分子式:C29H26F3N5O3
分子量：549.54
溶解度:Soluble in DMSO
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine[1].

[1]. Li CC, et al. Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling. J Clin Pharmacol. 2017 Nov 14. doi: 10.1002/jcph.1021.